Citation Impact
Citing Papers
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
2009 StandoutScience
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction
2006
Cadherin-11 in Synovial Lining Formation and Pathology in Arthritis
2007 Science
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow
2012
Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.
1998
Effects of inflammatory and anti‐inflammatory cytokines on the bone
2011
Inflammation-Induced Bone Loss: Can it Be Prevented?
2006
The complexities of skeletal biology
2003 StandoutNature
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Dectin-1: a signalling non-TLR pattern-recognition receptor
2005
Regulation of the differentiation and function of osteoclasts
2000
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
Inflammation and metabolic disorders
2006 StandoutNature
GP130/OSMR is the only LIF/IL‐6 family receptor complex to promote osteoblast differentiation of calvaria progenitors
2005
Tumor-Associated Macrophages in Breast Cancer
2002
Foreign body reaction to biomaterials
2008 Standout
Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells
1999
Monocyte and macrophage heterogeneity
2005 Standout
Breast cancer cells induce osteoclast formation by stimulating host IL‐11 production and downregulating granulocyte/macrophage colony‐stimulating factor
2004
Impaired skeletal development in interleukin‐6–transgenic mice: A model for the impact of chronic inflammation on the growing skeletal system
2006
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2006
Pathogenesis of osteoporosis
2003
TRANCE/RANKL Knockout Mice Are Protected from Bone Erosion in a Serum Transfer Model of Arthritis
2001
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
The expression of osteoclast markers on foreign body giant cells
1994
Reaching a Genetic and Molecular Understanding of Skeletal Development
2002 Standout
β1 and β2 Integrins Mediate Adhesion during Macrophage Fusion and Multinucleated Foreign Body Giant Cell Formation
2002
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Inhibition of bone resorption by 17β-estradiol in human bone marrow cultures
1998
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Tissue-resident macrophages
2013 Standout
Dynamic control over cell adhesive properties using molecular-based surface engineering strategies
2009 StandoutNobel
Identification of Committed Mononuclear Precursors for Osteoclast-Like Cells Formed in Long Term Human Marrow Cultures*
1990
Tumor Necrosis Factor-α Mediates Orthopedic Implant Osteolysis
1999
Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation
2000
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
How antirheumatic drugs protect joints from damage in rheumatoid arthritis
2008
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Expression of osteoclast differentiation factor in rheumatoid arthritis
2000
Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates
2005
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Tumor necrosis factor α‐mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin
2002
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Bone Remodeling
2006
Modulation of Osteoclast Differentiation
1992
GP130 cytokines and bone remodelling in health and disease
2010
Inflammatory Mediators as Essential Elements in Bone Remodeling
2003
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
2002
Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines
2001
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
2010
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Osteoclast differentiation and activation
2003 StandoutNature
Current Concepts Review - Cellular Biology of Bone-Resorbing Cells*
1996
Origin and physiological roles of inflammation
2008 StandoutNature
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease
2011
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages
2007 StandoutNobel
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption
2008
Mechanisms of TNF-α– and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis
2003
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Cytokine receptor profile of arthroplasty macrophages, foreign body giant cells and mature osteoclasts
1999
Osteoclast-Like Cell Formation and its Regulation by Osteotropic Hormones in Mouse Bone Marrow Cultures*
1988
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ
2000 Nature
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression
2002
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Lessons from animal models of arthritis
2002
Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling
2002
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell Cultures
1998
A new self: MHC-class-I-independent Natural-killer-cell self-tolerance
2005
Repair of Local Bone Erosions and Reversal of Systemic Bone Loss Upon Therapy with Anti-Tumor Necrosis Factor in Combination with Osteoprotegerin or Parathyroid Hormone in Tumor Necrosis Factor-Mediated Arthritis
2004
Leptin Inhibits Bone Formation through a Hypothalamic Relay
2000 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Macrophages in human breast disease: a quantitative immunohistochemical study
1988
Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen‐induced arthritis
2004
Osteoclasts are essential for TNF-α–mediated joint destruction
2002
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
NK CELL RECOGNITION
2004 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4
2010
The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption
2000
Risedronate Directly Inhibits Osteoclast Differentiation and Inflammatory Bone Loss
2009
Bone Resorption by Osteoclasts
2000 StandoutScience
Osteoclasts and Arthritis
2009
Mechanisms of TNF-α– and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis
2003
MACROPHAGE RECEPTORS AND IMMUNE RECOGNITION
2005
Macrophage response to cross-linked and conventional UHMWPE
2003
Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with Osteoclast-Like Cell Formation*
1999
Human Osteoclast-Like Cells Are Formed from Peripheral Blood Mononuclear Cells in a Coculture with SaOS-2 Cells Transfected with the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Gene
1999
Mast cells mediate acute inflammatory responses to implanted biomaterials
1998
Adherent Endotoxin on Orthopedic Wear Particles Stimulates Cytokine Production and Osteoclast Differentiation
2001
Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts
2009
Focally regulated endothelial proliferation and cell death in human synovium.
1998
Osteoprotegerin Produced by Osteoblasts Is an Important Regulator in Osteoclast Development and Function*
2000
Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo
2001
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO
2003
Osteoclasts are essential for TNF-α–mediated joint destruction
2002
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system
1999 StandoutNobel
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
1999 Standout
Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1
1999
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
1999
Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer
2006
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Hypoxia‐inducible factor regulates osteoclast‐mediated bone resorption: role of angiopoietin‐like 4
2010
Antibody to Langerin/CD207 localizes large numbers of CD8α + dendritic cells to the marginal zone of mouse spleen
2009 StandoutNobel
IL-17 Promotes Bone Erosion in Murine Collagen-Induced Arthritis Through Loss of the Receptor Activator of NF-κB Ligand/Osteoprotegerin Balance
2003
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Immunophenotype of multinucleated and mononuclear cells in giant cell lesions of bone and soft tissue.
1992
Therapeutic Approaches to Bone Diseases
2000 Science
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Works of J Quinn being referenced
IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice
2008
Calcitonin receptor antibodies in the identification of osteoclasts
1999
Localization of RANKL (receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues
1999
Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro
2007
Extracellular matrix receptor and platelet antigens on osteoclasts and foreign body giant cells
1991
Osteoclast Inhibitory Lectin, a Family of New Osteoclast Inhibitors
2002
Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes
2010
Leucocyte common antigen is present on osteoclasts
1987
Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways
2004
Phenotypic characterisation of mononuclear and multinucleated cells of giant cell tumour of bone
1992
Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells
1998
New sites of cellular vitronectin receptor immunoreactivity detected with osteoclast-reacting monoclonal antibodies 13C2 and 23C6
1990
Modulation of osteoclast formation
2004
The generation of highly enriched osteoclast-lineage cell populations
2002
CELLS OF THE MONONUCLEAR PHAGOCYTE SERIES DIFFERENTIATE INTO OSTEOCLASTIC LACUNAR BONE RESORBING CELLS
1996
The origin and nature of stromal osteoclast-like multinucleated giant cells in breast carcinoma: implications for tumour osteolysis and macrophage biology
1989
Activated T Lymphocytes Support Osteoclast Formation in Vitro
1999
A Novel Osteoblast-derived C-type Lectin That Inhibits Osteoclast Formation
2001
Bone resorption by macrophage polykaryons of giant cell tumour of tendon sheath
1991
Interleukin‐6 modulates production of T lymphocyte–derived cytokines in antigen‐induced arthritis and drives inflammation‐induced osteoclastogenesis
2005
Osteoclast Inhibitory Lectin, an Immune Cell Product That Is Required for Normal Bone Physiology in Vivo
2008
Characterization of Sugar Binding by Osteoclast Inhibitory Lectin
2004
Human Osteoclast Formation from Blood Monocytes, Peritoneal Macrophages, and Bone Marrow Cells
1998
Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis
2000
Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-κB Ligand
2001
Cellular and hormonal mechanisms associated with malignant bone resorption.
1994
Bone resorption by cells isolated from rheumatoid synovium.
1992
Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function.
1990
A Combination of Osteoclast Differentiation Factor and Macrophage-Colony Stimulating Factor Is Sufficient for both Human and Mouse Osteoclast Formation in Vitro
1998
Interleukin-11 Receptor Signaling Is Required for Normal Bone Remodeling
2005
Tumour infiltrating macrophages are capable of bone resorption
1992
Resorption of bone by inflammatory cells derived from the joint capsule of hip arthroplasties
1992
The human osteoclast precursor circulates in the monocyte fraction.
1996
Use of monoclonal antibodies to recognise osteoclasts in routinely processed bone biopsy specimens.
1991
Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells.
1996
Immunocytochemical analysis of the human osteoclast: phenotypic relationship to other marrow-derived cells.
1988
Osteoclast Inhibitory Lectin (OCIL), an immune cell product that is required for normal bone physiology in vivo
2009
Immunocytochemical analysis of human synovial lining cells: phenotypic relation to other marrow derived cells.
1991
Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor.
1996
Effect of decalcification agents on immunoreactivity of cellular antigens.
1987
A Combination of Osteoclast Differentiation Factor and Macrophage-Colony Stimulating Factor Is Sufficient for both Human and Mouse Osteoclast Formation in Vitro
1998
Cardiotrophin-1 Is an Osteoclast-Derived Stimulus of Bone Formation Required for Normal Bone Remodeling
2008
The Heat Shock Protein 90 Inhibitor, 17-Allylamino-17-demethoxygeldanamycin, Enhances Osteoclast Formation and Potentiates Bone Metastasis of a Human Breast Cancer Cell Line
2005
Cellular and hormonal factors influencing monocyte differentiation to osteoclastic bone-resorbing cells.
1994
Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions
2001
Osteoclasts contain macrophage and megakaryocyte antigens
1986
Polymethylmethacrylate-induced inflammatory macrophages resorb bone
1992